JAK2 and Miyoshi myopathy: The results demonstrated that the p-STAT3, p-PI3K, p-Akt, c-Myc, and p-JAK2 protein concentrations in DHCE-treated MM cells were markedly reduced dose-dependently, whereas the total JAK2 and STAT3 levels were unaffected (Figure 4C).